Medicofarma Biotech Spolka Akcyjna
A biotech R&D company developing innovative drugs and devices with a focus on oncology therapies.
MDB | WAR
Overview
Corporate Details
- ISIN(s):
- PLINBOK00010
- LEI:
- 259400W39H7UHW9EJP66
- Country:
- Poland
- Address:
- Warszawa Sokołowska 9/U19, 01-142 Warszawa
- Website:
- http://medicofarmabiotech.pl
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Medicofarma Biotech is a research and development company operating in the biotechnology sector. The company's core mission is to design, refine, and introduce innovative drugs, medical devices, and biotechnological products. It focuses on developing breakthrough solutions for the prevention and treatment of modern-age diseases, with a particular emphasis on innovative oncology therapies. The company's R&D center collaborates with pharmaceutical producers and scientific institutions, providing specialized personnel and equipment for the initial pre-formulation stages of generic medicinal and cosmetic products.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-04-18 18:43 |
Share Issue/Capital Change
Wprowadzenie do ASO na rynku NewConnect akcji serii G i H oraz złożenie wniosku…
|
Polish | 1.3 KB | ||
| 2024-03-06 19:35 |
Capital/Financing Update
Zawarcie kolejnego aneksu do umowy pożyczki z podmiotami powiązanymi - Content …
|
Polish | 3.3 KB | ||
| 2024-01-03 22:51 |
Share Issue/Capital Change
Złożenie wniosku o wprowadzenie akcji serii G i H do obrotu w ASO na rynku NewC…
|
Polish | 1.7 KB | ||
| 2024-01-02 17:16 |
Share Issue/Capital Change
Korekta raportu bieżącego ESPI nr 11/2023 - Content (PL)
|
Polish | 4.5 KB | ||
| 2023-12-31 19:41 |
Capital/Financing Update
Zawarcie kolejnego aneksu do umowy pożyczki z podmiotami powiązanymi - Content …
|
Polish | 2.1 KB | ||
| 2023-12-31 19:33 |
Legal Proceedings Report
Zawarcie umów ograniczających rozporządzanie akcjami Spółki - Content (PL)
|
Polish | 2.9 KB | ||
| 2023-12-31 19:24 |
Investor Presentation
Strategia na lata 2024-2026
|
Polish | 2.6 MB | ||
| 2023-12-31 19:24 |
Business and Financial Review
Przyjęcie strategii Spółki na lata 2024 - 2026 - Content (PL)
|
Polish | 1.8 KB | ||
| 2023-10-26 22:42 |
Capital/Financing Update
Zawarcie aneksu do umowy pożyczki z podmiotami powiązanymi - Content (PL)
|
Polish | 2.5 KB | ||
| 2023-10-23 20:42 |
Regulatory Filings
Zawarcie umowy o dofinansowanie projektu wybranego w ramach konkursu NUTRITECH …
|
Polish | 6.3 KB | ||
| 2023-10-11 21:07 |
Legal Proceedings Report
Otrzymanie wyników wstępnego międzynarodowego poszukiwania dot. stanu techniki …
|
Polish | 1.9 KB | ||
| 2023-07-20 19:38 |
Report Publication Announcement
Najwyższa ocena merytoryczna wniosku dotacyjnego NUTRITECH - Content (PL)
|
Polish | 1.2 KB | ||
| 2023-07-19 18:01 |
Regulatory Filings
Informacja o uzyskaniu certyfikatu GMP - Content (PL)
|
Polish | 716 bytes | ||
| 2023-06-30 22:59 |
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Walnym Zgroma…
|
Polish | 766 bytes | ||
| 2023-06-02 15:22 |
Management Reports
Medicofarma_Biotech_SA_Sprawozdanie_Rady_Nadzorczej_2022_20230602_sent.pdf
|
Polish | 345.3 KB |
Automate Your Workflow. Get a real-time feed of all Medicofarma Biotech Spolka Akcyjna filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Medicofarma Biotech Spolka Akcyjna
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Medicofarma Biotech Spolka Akcyjna via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
